The Impact of Obesity on Surgery in Gynaecologic Oncology: Our Experience
Journal Title: GUJARAT CANCER SOCIETY RESEARCH JOURNAL - Year 2016, Vol 18, Issue 1
Abstract
Surgery represents the mainstay in the treatment of gynecological cancers. It is believed to be more difficult in obese patients and increases the incidence of intraoperative and postoperative complications in these patients. This study was carried out to estimate the morbidity, adequacy of surgery and complication rates in obese women undergoing gynecological cancer surgery. We did a retrospective study of patients operated in a single unit in the department of gynecologic oncology from January 2009-June 2011 with BMI >27.5kg/m2 (obese). During the study period, 20 obese patients were operated amongst which 11were of endometrial cancer, 5 were of ovarian mass, 2 were of cervical and vulvar cancer each. Mean BMI was 32kg/m2. Mean operative time was three hours and mean blood loss was 294 ml. Lymphadenectomy was done in 66% of patients. Optimal surgery was possible in all the patients. Mean hospital stay was 17.5 days. There were no major intra-operative complications in any case. Superficial wound dehiscence occurred in seven patients. Obesity per se, without severe co-morbid diseases, is not a contraindication to surgical treatment. Such patients should not be considered for suboptimal treatment strategies. Special precautions should be taken during preoperative evaluation. A multidisciplinary approach involving experienced surgeon, anesthetist, physician, physiotherapist and intensivist is mandatory
Authors and Affiliations
Pariseema S1, Dave, Bijal Patel, Heena Chawla, Meeta Mankad
Keywords
Related Articles
- EP ID EP194060
- DOI -
- Views 123
- Downloads 0
Epithelial Mesenchymal Transition Markers in Breast Cancer
Epithelial-mesenchymal transition (EMT) is defined by the loss of epithelial characteristics and the acquisition of a mesenchymal phenotype. It can be associated with increased aggressiveness, and invasive and metastatic...
Plasmablastic Lymphoma: A Diagnostic Dilemma
Plasmablastic lymphoma (PBL) has been described as a rapidly progressive and fatal, CD20 negative, CD138 positive diffuse large cell lymphoma with plasmoblastic features. PBL is heterogenous in terms of clinical presenta...
Department of Orthopedic Oncology
Department of Orthopedic Oncology, a specialized branch in oncology, is the first kind in India managing and operating complex bone and soft tissue tumors. It is one of the foremost department to start modern orthopedic...
Isolated Central Nervous System Blast Crises in Chronic Myelogenous Leukemia
Chronic myeloid leukemia (CML) is a chronic myeloproliferative disorder, currently treated with tyrosine kinase inhibitors. Uncontrolled CML eventually progresses to accelerated and blast crises, which is often medullary...
Extraskeletal Osteosarcoma Arising from Kidney: A Case Report
Osteosarcoma is a highly aggressive malignant mesenchymal origin tumour most commonly arising from bone. Extraskeletal osteosarcoma is a very rare entity with very few reported cases worldwide. We hereby report of case e...